University of Alabama Birmingham Researchers to Study One-Dose Antibiotic for Prevention of Maternal and Infant Sepsis
June 19, 2020
June 19, 2020
BIRMINGHAM, Alabama, June 19 -- The University of Alabama Birmingham campus issued the following news:
Researchers from the University of Alabama at Birmingham School of Medicine -- with support from the National Institutes of Health and the Bill & Melinda Gates Foundation -- will conduct a clinical trial to assess whether a single oral dose of the antibiotic azithromycin during labor reduces the risk of maternal and infant bacterial infection and death in seven low- and middle- . . .
Researchers from the University of Alabama at Birmingham School of Medicine -- with support from the National Institutes of Health and the Bill & Melinda Gates Foundation -- will conduct a clinical trial to assess whether a single oral dose of the antibiotic azithromycin during labor reduces the risk of maternal and infant bacterial infection and death in seven low- and middle- . . .